Spectral AI, Inc. Class A

Stage 4 · Declining · week 10

As of Oct 22, 2026, Spectral AI is in Stage 4, the downtrend phase, now in week 10 (since Aug 17, 2026). It closed at $1.50, 44.0% below its 52-week high and below its 200-day average, which is rising.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. More about the company

$1.50

-0.66% today

$48.3M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is MDAI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 44w

S4 15w

S3 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 4w → S3 1w → S4 44w → S1 3w → S4 15w → S1 4w → S2 10w → S3 5w → S4 8w → S1 3w → S2 10w → S3 14w → S4 8w → S1 2w → S4 8w → S1 4w → S2 7w → S3 5w → S4 10w current

Total tracked: 164 weeks across 19 stage runs.

MDAI among Medical Devices79th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…79	MDAISpectral AI, Inc. Class A	Stage 4 · wk 10	29	−9.6%

vs 52W High

-44.0%

$1.20 lo$2.68 hi

44.0% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 10

1w13w26w

Week 10, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-12.1%

200 DMA: $1.71 · rising

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.45x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-9.6%

-8.5%

-16.7%

YTD

+3.4%

-37.5%

Scan Membership

Breakout Watch

Latest: 2024-12-30

5 appearances in last 60 days. First seen: 2022-01-18.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 10 · Vol 0.45x

2026-10-21S4

Wk 10 · Vol 0.37x

2026-10-20S4

Wk 10 · Vol 0.45x

2026-10-19S4

Wk 9 · Vol 0.36x

2026-10-16S4

Wk 9 · Vol 0.69x

2026-10-15S4

Wk 9 · Vol 1.23x

2026-10-14S4

Wk 9 · Vol 1.58x

2026-10-13S4

Wk 9 · Vol 1.22x

2026-10-12S4

Wk 8 · Vol 0.51x

2026-10-09S4

Wk 8 · Vol 1.06x

2026-10-08S4

Wk 8 · Vol 0.66x

2026-10-07S4

Wk 8 · Vol 0.58x

Moving averages & range

50 DMA

$1.60

200 DMA

$1.71

52W High

$2.68

52W Low

$1.20

5D Low

$1.50

Resistance levels (recent highs)

20d High

$1.69

60d High

$1.75

120d High

$2.68

250d High

$2.68

Next resistance

+12.7%

to 20d High

Dividend Yield

0.00%

P/B -4.0

Spectral AI: quick answers

What stage is Spectral AI in?

As of Oct 22, 2026, Spectral AI (MDAI) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 17, 2026 and is in week 10. What the four stages mean

Is Spectral AI in an uptrend?

No. Spectral AI is in a Stage 4 downtrend. It trades 12.1% below its 200-day average, which is rising.

How far is Spectral AI from its 52-week high?

Spectral AI closed at $1.50 on Oct 22, 2026, 44.0% below its 52-week high of $2.68. Its 52-week low is $1.20.

How has Spectral AI performed over the past year?

As of Oct 22, 2026, Spectral AI is down 37.5% over the past year and up 3.4% so far in 2026.

Which sector and industry is Spectral AI in?

Spectral AI is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.